Certain Covid-19 vaccines may lead to nerve damage, according to a bombshell report by the Epoch Times.
Guillain-Barré syndrome (GBS) is a “rare disorder” that can lead to nerve damage and potential paralysis, according to the Centers for Disease Control and Prevention (CDC).
A new report by the Epoch Times suggests that recipients of the AstraZeneca vaccine could be at higher risk of GBS.
As the vaccination rate continues to rise, an increasing number of side effects are being reported. Research indicates that COVID-19 viral vector-based vaccines increase the risk of Guillain-Barré syndrome (GBS) by three to four times compared to mRNA-based vaccines.
Increasing evidence suggests an association between COVID-19 vaccines and Guillain-Barré Syndrome. One study revealed an increase in GBS cases within 42 days of receiving the first dose of the AstraZeneca vaccine.
The researchers suggest a potential link between the AstraZeneca vaccine and the increased risk of GBS.
After assessing the risk factors for GBS following COVID-19 vaccination, it was found that viral vector-based vaccines were linked to a three-to-fourfold higher risk of GBS compared to mRNA-based vaccines.
Read the full article by Ellen Wan at the Epoch Times here.
AstraZeneca has been named in two different lawsuits in its home country of England, with one person claiming they suffered serious brain damage after taking its Covid vaccine.
AstraZeneca’s Covid-19 vaccine, known by its brand name Vaxzevria, has been approved by Health Canada, which claims it has “high standards and rigor.” Despite the risk of side effects, Vaxzevria is still available in the country.
Toronto 99 has not been able to independently verify the claims made by Ellen Wan at the Epoch Times. The lawsuits against AstraZeneca are still before the courts and none of the claims contained have been proven.
Did you like this article? Consider a small donation. If you can’t afford to donate, consider sharing this article on your favourite social media platform!